The reversal of EMT phenotypes by RAPA and DAPT further confirms that the effects of SNHG1 are mediated via the ULK1-Notch1 axis, highlighting its potential as a therapeutic target in Barrett’s esophagus. This evidence concerns the gene SNHG1 and esophageal adenocarcinoma.